Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation: A Randomized, Double-blind, Controlled Trial

NCT05450328 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT05450328
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450328 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation: A Randomized, Double-blind, Controlled Trial
Lead sponsor
Montreal Heart Institute
Phase
Phase 2
Overall status
Recruiting
Start date
December 10, 2025
Completion date
December 1, 2028
Enrollment
141 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

right heart failure, right ventricular dysfunction